ABA Health Law Webinars and Events: Off-Label Marketing and Free Speech; FDA Medical Device Law Fundamentals
Wednesday, 11/12/14: Off-label Marketing and Free Speech: Caronia and the Future of Speech in Therapeutic Product Promotion
Information:
The landmark decision in U.S. v. Caronia has emboldened drugs and biologics makers to contest charges of off-label marketing, including the currently pending California False Claims Act case regarding unapproved uses of Integrilin. This webinar will focus on Caronia and other First Amendment cases, including IMS Health Inc. v. Sorrell, evaluating the prosecution of off-label promotion against the therapeutic products industries.
The webinar will:
Provide participants with key factual and procedural information regarding Caronia and related First Amendment cases to provide discussion context
Present and assess government and industry perspectives to the litigation and future impacts
Discuss how the cases may practically impact current and future prosecutions as well as actions taken by therapeutic product companies
Webinar
-1.5 CLE credits requested
-Wednesday, 11/12/14
-12:00 PM - 1:30PM Eastern
-$115 - $150 ABA Members; $99 Government
http://shop.americanbar.org/ebus/ABAEventsCalendar/EventDetails.aspx?productId=137218496&sc_cid=PM
**********************************************
Thursday, 11/20/14: FDA Medical Device Law Fundamentals
Information:
In this webinar, a panel of experienced FDA attorneys will give you an overview of the responsibilities of the FDA and its impact on the m...
Source: Policy and Medicine - Category: American Health Authors: Thomas Sullivan Source Type: blogs
More News: Advertising | Clinical Trials | Eptifibatide | Government | Health | Health Medicine & Bioethics Commentators | Integrilin | Legislation | Marketing | Medical Devices | Medical Ethics | Medical Law | Politics | Science | Training | Universities & Medical Training